Lipidomic changes in the liver of beagle dogs associated with Toxocara canis infection

Haoyu Li(Qingdao University), Wen-Bin Zheng(Shanxi Agricultural University), Yang Zou(Guangxi University), Yue Xu(Shanxi Agricultural University), Xing‐Quan Zhu(Shanxi Agricultural University), Shi-Chen Xie(Hunan Agricultural University), Hany M. Elsheikha(University of Nottingham), Lang Cai(Shanxi Agricultural University)
Frontiers in Cellular and Infection Microbiology
September 13, 2022
10.3389/fcimb.2022.890589
Cited by 5

Related Papers

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives
|Trends in Parasitology|2019|197
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway
|Frontiers in Cellular and Infection Microbiology|2020|111
The protein phosphatase 2A holoenzyme is a key regulator of starch metabolism and bradyzoite differentiation in Toxoplasma gondii
|Nature Communications|2022|83